search
Back to results

Feasibility Trial of a Lifestyle Intervention for CHR-P

Primary Purpose

Prodromal Schizophrenia, Psychosis, Psychological Disorder

Status
Enrolling by invitation
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Health Behaviors Group
Sponsored by
University of California, Los Angeles
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Prodromal Schizophrenia focused on measuring early intervention, lifestyle intervention, clinical high risk for psychosis, health behavior

Eligibility Criteria

13 Years - 17 Years (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. between 13 and 17 years old
  2. able to sign and provide informed consent (assent for minors)
  3. meet criteria for CHR-P using the Structured Interview for Psychosis-Risk Syndromes (SIPS).
  4. Must have a primary caregiver willing to participate who speaks fluent English

Exclusion Criteria:

  1. current or lifetime DSM-5 psychotic disorder
  2. impaired intellectual functioning (IQ <65)
  3. history of neurological disorder
  4. traumatic brain injury (≥7 on TBI screening tool)
  5. significant substance use that makes CHR-P diagnosis ambiguous

Sites / Locations

  • University of California, Los Angeles

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Health Behavior Group

Arm Description

9- week health behavior promotion group intervention

Outcomes

Primary Outcome Measures

Participant Recruitment and Retention
Feasibility will be measured by recruitment (participants approached/ participants enrolled) and retention (participants enrolled/ participants completed at least two-thirds of the intervention). Feasibility data will be summarized by the percent recruited, the percent retained by group and the mean and median number of sessions attended by group. The percent who attended each session by group over time will also be reported. Good feasibility will be defined as 70% of those enrolled completing at least two-thirds of the intervention (6 sessions).
Change in Physical Activity
The mean profile from baseline to post-treatment for physical activity as assessed by the International Physical Activity Questionnaire - Short Form (IPAQ-SF; Craig et al., 2017). Activity levels will be self-report.
Change Sleep Habits
Sleep will be assessed via self-report on the PROMIS Pediatric Sleep Disturbance scale (Buysse, et al., 2010). The Pediatric Sleep Disturbance Scale consists of 15 items rated 1 = Never, 2 = Almost Never, 3 = Sometimes, 4 = Almost Always, and 5 = Always, with a higher score indicating more sleep disturbance.
Change in Subjective Stress
Participant subjective stress will be assessed via the 10-item self-report Perceived Stress Scale ( PSS; Cohen et al., 1983).The PSS consists of 10 items rated 0= Never to 4= Very Often, with a higher score suggesting more stress.
Change in Substance Use
Alcohol and drug use will be measured by clinician rated on the Alcohol Use Scale and Drug Use Scale (AUS/DUS; Drake et al., 1996). This measure rates frequency and impairment associated with alcohol and drug use. Alcohol and drug use are rated on both frequency (0= no use to 5= almost daily) and impairment (0= abstinent to 5= dependence with institutionalization). A rating of 3 or higher on impairment corresponds with substance use disorder.
Change in Diet
Change in diet will be measured on the ASA24. This dietary assessment uses 24-hour recall to assess nutrition quality and provides measure of total energy intake and macronutrients.

Secondary Outcome Measures

Social Validity as assessed by the Semi-Structured Interview for Social Validation
The social validity of the intervention will be described qualitatively using a modified version of the Semi-Structured Interview for Social Validation. This interview measure includes questions directed at assessing the significance of the goals of the intervention, the acceptability of the procedures used, and the importance of the effects of the intervention. A thematic analysis procedure will be utilized for qualitative analysis of the interviews.

Full Information

First Posted
August 1, 2022
Last Updated
April 4, 2023
Sponsor
University of California, Los Angeles
search

1. Study Identification

Unique Protocol Identification Number
NCT05532683
Brief Title
Feasibility Trial of a Lifestyle Intervention for CHR-P
Official Title
Development and Feasibility of a Lifestyle Group Intervention for Youth at Clinical High Risk for Psychosis
Study Type
Interventional

2. Study Status

Record Verification Date
April 2023
Overall Recruitment Status
Enrolling by invitation
Study Start Date
April 4, 2023 (Actual)
Primary Completion Date
May 30, 2023 (Anticipated)
Study Completion Date
July 31, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of California, Los Angeles

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The present study will assess the feasibility and social validity of an adjunctive health promotion group for youth and clinical high risk for psychosis (CHR-P). Youth participating in treatment at the Center for the Assessment and Prevention of Prodromal Sates (CAPPS) will be invited to participate in a weekly, adjunctive, closed psychoeducation group focused on sharing health promotion strategies and increasing health behaviors (e.g. improved sleep habits, increased participation in physical activity). The aim of the group will be to provide psychoeducation on lifestyle risk and protective factors for youth at risk for psychosis (i.e. experiencing subthreshold psychosis symptoms). Topics covered will include psychoeducation, goal setting, stress management, sleep, physical activity, substance use, and nutrition. Evidence-based strategies to decrease risk factors and promote protective lifestyle factors for mental illness will be reviewed. Group leaders will utilize a motivational interviewing approach to facilitate the group. The group will complete nine weekly group sessions. The goal of our research is to 1) determine the feasibility of a novel group-based health promotion intervention, 2) assess the social validity of the group, 3) measure the effects of the intervention on stress, sleep, physical activity, substance use, and nutrition, and 4) measure preliminary effects on symptoms and functioning.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Prodromal Schizophrenia, Psychosis, Psychological Disorder, Psychological Stress
Keywords
early intervention, lifestyle intervention, clinical high risk for psychosis, health behavior

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
One group of 12 participants identified as at clinical high-risk for psychosis (CHR-P) will be recruited to participate in a 9-week health behavior promotion/lifestyle intervention.
Masking
None (Open Label)
Allocation
N/A
Enrollment
12 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Health Behavior Group
Arm Type
Experimental
Arm Description
9- week health behavior promotion group intervention
Intervention Type
Behavioral
Intervention Name(s)
Health Behaviors Group
Intervention Description
The proposed intervention will include eight modules across nine weekly group sessions targeting psychoeducation of CHR-P symptoms, goal setting, physical activity, sleep, substance use, nutrition, and evidence-based strategies for stress management. Intervention facilitators will utilize motivational interviewing (MI; Miller & Rollnick, 2012) strategies to engage youth in goal setting to target change in health promotion behaviors. Caregivers will be invited to join at the end of each session for a 10-minute check-out where an outline of content covered and patient goals for the week will be shared.
Primary Outcome Measure Information:
Title
Participant Recruitment and Retention
Description
Feasibility will be measured by recruitment (participants approached/ participants enrolled) and retention (participants enrolled/ participants completed at least two-thirds of the intervention). Feasibility data will be summarized by the percent recruited, the percent retained by group and the mean and median number of sessions attended by group. The percent who attended each session by group over time will also be reported. Good feasibility will be defined as 70% of those enrolled completing at least two-thirds of the intervention (6 sessions).
Time Frame
Across Intervention: 9 weeks
Title
Change in Physical Activity
Description
The mean profile from baseline to post-treatment for physical activity as assessed by the International Physical Activity Questionnaire - Short Form (IPAQ-SF; Craig et al., 2017). Activity levels will be self-report.
Time Frame
Change from baseline (pre-intervention) to 9- week post-intervention
Title
Change Sleep Habits
Description
Sleep will be assessed via self-report on the PROMIS Pediatric Sleep Disturbance scale (Buysse, et al., 2010). The Pediatric Sleep Disturbance Scale consists of 15 items rated 1 = Never, 2 = Almost Never, 3 = Sometimes, 4 = Almost Always, and 5 = Always, with a higher score indicating more sleep disturbance.
Time Frame
Change from baseline (pre-intervention) to 9- week post-intervention
Title
Change in Subjective Stress
Description
Participant subjective stress will be assessed via the 10-item self-report Perceived Stress Scale ( PSS; Cohen et al., 1983).The PSS consists of 10 items rated 0= Never to 4= Very Often, with a higher score suggesting more stress.
Time Frame
Change from baseline (pre-intervention) to 9- week post-intervention
Title
Change in Substance Use
Description
Alcohol and drug use will be measured by clinician rated on the Alcohol Use Scale and Drug Use Scale (AUS/DUS; Drake et al., 1996). This measure rates frequency and impairment associated with alcohol and drug use. Alcohol and drug use are rated on both frequency (0= no use to 5= almost daily) and impairment (0= abstinent to 5= dependence with institutionalization). A rating of 3 or higher on impairment corresponds with substance use disorder.
Time Frame
Change from baseline (pre-intervention) to 9- week post-intervention
Title
Change in Diet
Description
Change in diet will be measured on the ASA24. This dietary assessment uses 24-hour recall to assess nutrition quality and provides measure of total energy intake and macronutrients.
Time Frame
Change from baseline (pre-intervention) to 9- week post-intervention
Secondary Outcome Measure Information:
Title
Social Validity as assessed by the Semi-Structured Interview for Social Validation
Description
The social validity of the intervention will be described qualitatively using a modified version of the Semi-Structured Interview for Social Validation. This interview measure includes questions directed at assessing the significance of the goals of the intervention, the acceptability of the procedures used, and the importance of the effects of the intervention. A thematic analysis procedure will be utilized for qualitative analysis of the interviews.
Time Frame
9-week post-intervention

10. Eligibility

Sex
All
Minimum Age & Unit of Time
13 Years
Maximum Age & Unit of Time
17 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: between 13 and 17 years old able to sign and provide informed consent (assent for minors) meet criteria for CHR-P using the Structured Interview for Psychosis-Risk Syndromes (SIPS). Must have a primary caregiver willing to participate who speaks fluent English Exclusion Criteria: current or lifetime DSM-5 psychotic disorder impaired intellectual functioning (IQ <65) history of neurological disorder traumatic brain injury (≥7 on TBI screening tool) significant substance use that makes CHR-P diagnosis ambiguous
Facility Information:
Facility Name
University of California, Los Angeles
City
Los Angeles
State/Province
California
ZIP/Postal Code
90024
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices). Treatment manual will also be made available. Proposals should be directed to bernalynruiz@mednet.ucla.edu. To gain access, data requestors will need to sign a data access agreement and provide methodologically sound research proposal.
IPD Sharing Time Frame
Data will be made available beginning 3 months and ending 5 years following article publication.
IPD Sharing Access Criteria
Those requesting access should have Ph.D. or equivalent level degree in psychology or a related field. Researchers should also provide a methodologically sound proposal.

Learn more about this trial

Feasibility Trial of a Lifestyle Intervention for CHR-P

We'll reach out to this number within 24 hrs